Work

NSABP FR-2: Phase II study of durvalumab following neoadjuvant chemoRT in stage II-IV rectal cancer.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

Authors: Thomas J. George, Greg Yothers, James J. Lee, Samuel A. Jacobs, Melvin Deutsch, Carmen Joseph Allegra, Norman Wolmark

Institutions: University of Florida, NSABP Foundation, University of Pittsburgh, University of Pittsburgh Medical Center, NRG Oncology, UPMC Hillman Cancer Center, Allegheny Health Network

Language: English

Topic: Colorectal Cancer Surgical Treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4253275346

Cites:

Cited by: 5

Related to: 10